- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-06-0014977

Vvic Pharma Private Limited
About Vvic Pharma Private Limited
Data last updated:
Vvic Pharma Private Limited is a private limited company based in Ankleshwar, Gujarat, India. It operates in the chemical products or preparations of a kind used in the textiles segment of the chemicals sector. It was incorporated on 24 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24297GJ2020PTC114955. Its GSTIN is 24AAHCV4903H1ZE (Gujarat).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Jatin Rameshbhai Lathiya and Milan Bharatbhai Lathiya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 204 – C/3 GIDC Panoli, Ankleshwar, Gujarat, India – 394116.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.14 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹12.23 Lakh (net margin -3.9%) and EBITDA of ₹30.39 Lakh (EBITDA margin 9.7%).
As per MCA filings, the company has open charges of ₹2.85 Cr on record.
Vvic Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0014977).
Recognitions & Rankings of Vvic Pharma
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No 204 – C/3 GIDC Panoli, Ankleshwar, Gujarat, India – 394116
- IndustryChemicals, Chemical Products Or Preparations Of A Kind Used In The Textiles, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Vvic Pharma Private Limited
The main business activity of Vvic Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vvic Pharma Private Limited FY 2025 filings available
Vvic Pharma Private Limited reported revenue of ₹3.14 Cr (up 303% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Vvic Pharma Private Limited
Revenue rose 303% in the latest year. EBITDA rose 9% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Vvic Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹30.39 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹12.23 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vvic Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -3.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vvic Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Vvic Pharma Private Limited
Vvic Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jatin Rameshbhai Lathiya | Director | 24 Jul 2020 | 6 Years 2 Months | Current |
| Milan Bharatbhai Lathiya | Director | 24 Jul 2020 | 6 Years 2 Months | Current |
| Jiteshbhai Manjibhai Lakhani | Director | 24 Jul 2020 | 6 Years 2 Months | Current |
Peer Comparison of Vvic Pharma Private Limited
Vvic Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abhelfen Life Science Private Limited | ₹3.23 Cr (FY 2025) | •••• | •••• | 404.0% | •••• | Gandhinagar, Gujarat, India |
| Maruti Futuristic Pharma Private Limited | ₹3.2 Cr (FY 2025) | •••• | •••• | -25.0% | •••• | Bangalore, Karnataka, India |
| Headway Life Sciences Private Limited | ₹3.2 Cr (FY 2025) | •••• | •••• | 1156.0% | •••• | Bhopal, Madhya Pradesh, India |
| Mekanar Pharma Private Limited | ₹3.2 Cr (FY 2025) | •••• | •••• | 50.0% | •••• | Hyderabad, Telangana, India |
| Cil Laboratories Private Limited | ₹3.14 Cr (FY 2023) | •••• | •••• | 26590.0% | •••• | Kolkata, West Bengal, India |
| Vvic Pharma Private Limited this company | ₹3.14 Cr (FY 2025) | •••• | •••• | 303.0% | •••• | Ankleshwar, Gujarat, India |
| Sthree Chemicals Private Limited | ₹3.11 Cr (FY 2024) | •••• | •••• | -53.0% | •••• | Walajapet, Tamil Nadu, India |
| Supreme Drugs Private Limited | ₹3.08 Cr (FY 2024) | •••• | •••• | 1350.0% | •••• | Banaskatha, Gujarat, India |
| Innosyn Life Sciences Private Limited | ₹3.04 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Hyderabad, Telangana, India |
| Nic Bioscience Private Limited | ₹3.03 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Ankleshwar, Gujarat, India |
| Vandana Life Sciences Private Limited | ₹2.82 Cr (FY 2025) | •••• | •••• | -54.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Vvic Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Vvic Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vvic Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Nov 2022 | Others | ₹2.85 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Vvic Pharma Private Limited
Vvic Pharma Private Limited has a workforce of 0 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vvic Pharma Private Limited
Vvic Pharma Private Limited has 5 board changes on record since 2020: 3 appointments and 2 cessations. The latest: Hareshkumar Nanjibhai Lathiya ceased to be Director on 13 Feb 2023.
Credit Ratings, Litigation & Regulatory Alerts for Vvic Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vvic Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vvic Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vvic Pharma Private Limited
Vvic Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAHCV4903H1ZE | Gujarat | Active | 27 Jul 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vvic Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vvic Pharma Private Limited
Vvic Pharma is an active private limited company based in Ankleshwar, Gujarat, India. The company works in chemical products or preparations of a kind used in the textiles, within the chemicals industry. It was incorporated on 24 July 2020 (6+ years old) and is registered under CIN U24297GJ2020PTC114955.
Vvic Pharma reported revenue of ₹3.14 Cr for FY 2025 (up 303% YoY).
Vvic Pharma has 3 current directors:
- Jatin Rameshbhai Lathiya - Director
- Milan Bharatbhai Lathiya - Director
- Jiteshbhai Manjibhai Lakhani - Director
Vvic Pharma reported a net loss of ₹12.23 Lakh (net margin -3.9%) and EBITDA of ₹30.39 Lakh (EBITDA margin 9.7%) for FY 2025, as per its filed financial statements.
The GSTIN of Vvic Pharma is 24AAHCV4903H1ZE, registered in Gujarat.
The CIN (Corporate Identification Number) of Vvic Pharma is U24297GJ2020PTC114955. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vvic Pharma was incorporated on 24 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Vvic Pharma by revenue are Abhelfen Life Science Private Limited, Maruti Futuristic Pharma Private Limited, Headway Life Sciences Private Limited, Mekanar Pharma Private Limited, Cil Laboratories Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Hareshkumar Nanjibhai Lathiya ceased to be Director on 13 Feb 2023. Rohitkumar Bhagwanbhai Dholakia ceased to be Director on 13 Feb 2023. Jatin Rameshbhai Lathiya was appointed as Director on 24 Jul 2020. Vvic Pharma has 5 board changes on record in total.
Yes, Vvic Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-06-0014977).
The registered office of Vvic Pharma is at Plot No 204 – C3 GIDC Panoli, Ankleshwar, Gujarat, India – 394116.